Insulin resistance and metabolic parameters in type 2 diabetic patients

European Journal of Internal Medicine

Volumn 13, Issue 2, 2002, Pages 108-114

  Metzler, W ^a   Fischer, S ^b   Kohler C ^c   Pistrosch, F ^b   Kindel, B ^b   Hanefeld, M ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Diabetes mellitus type 2; Dyslipidemia; Euglycemic hyperinsulinemic clamp; Hyperinsulinemia

Indexed keywords

FATTY ACID; GLUCOSE; HEMOGLOBIN A; INSULIN; LIPID;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0036121565     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(01)00202-3     Document Type: Article

References (36)

1. Insulin resistance in noninsulin-dependent diabetes mellitus: Does it exist and can it be measured?
2. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: Which defect is primary?
3. Banting lecture 1988. Role of insulin resistance in human disease
4. Lilly lecture 1987. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM
5. Reduced insulin-mediated glucose uptake by euglycemic clamp in offspring of patients with type 2 diabetes
6. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: Is cellular insulin resistance a secondary phenomenon?
7. Defects in insulin secretion and insulin action in non-insulin dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands
8. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight
9. Insulin resistance and secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus
10. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)
11. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: A metabolic comparison of Pima Indians and Caucasians
12. Assessment of insulin sensitivity in older adults using the hyperglycemic clamp technique
13. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes
14. Glucose clamp technique: A method for quantifying insulin secretion and resistance
15. Diminished beta cell secretory capacity in patients with non-insulin-dependent diabetes mellitus
16. Banting Lecture 1990. Beta cells in type II diabetes mellitus
17. Insulin resistance and non-insulin-dependent diabetes mellitus: Cellular and molecular mechanisms
18. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM
19. Insulin-sensitive and insulin-resistant variants in NIDDM
20. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus
21. Insulin sensitivity in subjects with type 2 diabetes
22. Insulin sensitivity and acute insulin response in African-Americans, Non-hispanic Whites, and Hispanics with NIDDM. The insulin resistance atherosclerosis study
23. The insulin resistance atherosclerosis study (IRAS): Objectives, design and recruitment results
24. For the IRAS investigators: Insulin sensitivity and atherosclerosis
25. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome
26. Pathophysiology of insulin resistance in human disease
27. Effects of weight reduction on obesity: Studies of carbohydrate and lipid metabolism
28. Dyslipidemias, insulin resistance and atherosclerosis
29. Insulin sensitivity in subjects with type 2 diabetes
30. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects
31. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
32. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes
33. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus
34. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status
35. Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance
36. Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study